Research Articles
A One-Two Punch for Leukemia: How a New Drug Combo Exploits Cancer's Weakness
Discover how pevonedistat and belinostat work synergistically to combat Acute Myeloid Leukemia by disrupting DNA repair mechanisms and triggering cancer cell death.
Breaking Ground: How a Cellular Destroyer Became a Cancer Fighter in Children
Exploring the groundbreaking Phase I clinical trial of bortezomib in pediatric leukemia patients and its impact on cancer treatment.
BRCA1's Molecular Scissors: How Targeted Protein Destruction Prevents Cancer
Explore how BRCA1 functions as a ubiquitin ligase, targeting specific proteins for destruction to prevent cancer development through DNA repair mechanisms.
RNF43 G659fs: How a Common Cancer Mutation Creates a Precision Treatment Opportunity
Discover how the RNF43 G659fs mutation in colorectal cancer creates a therapeutic vulnerability to PI3K/mTOR inhibitors, opening new precision medicine approaches.
The Hidden Genetic Switch Making Nasopharyngeal Carcinoma More Likely
Discover how MDM2 SNP309, a single genetic variation, increases nasopharyngeal carcinoma risk and metastasis in Chinese populations.
A New Ally in the Fight Against Endometrial Cancer: Disarming a Cellular "Master Switch"
Discover how HO-3867, a novel STAT3 inhibitor, selectively targets endometrial cancer cells while sparing healthy cells, offering promising new treatment possibilities.
A New Hope Against an Aggressive Cancer: Targeted Protein Degradation Takes Aim at Triple-Negative Breast Cancer
Revolutionary eEF2K degrader shows promising therapeutic efficacy against triple-negative breast cancer through targeted protein degradation technology.
The CUL4-RING E3 Ubiquitin Ligases: Master Conductors of Cellular Destiny
Explore the research progress of CUL4-RING E3 ubiquitin ligases, their role in cellular processes, therapeutic applications, and recent scientific discoveries.
The Unlikely Betrayal: How a DNA Repairman Helps Deactivate a Cancer-Fighting Hero
Discover how XPC protein collaborates with MDM2 to degrade p53 tumor suppressor, revealing new insights into cancer mechanisms and potential therapies.
Unlocking New Cancer Therapy: Targeting Protein Destruction in p53-Deficient Tumors
Discover how b-AP15 inhibition of USP14 and UCH37 deubiquitinating activity offers potential therapy for tumors with p53 deficiency